{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-050367","form_type":"8-K","ticker":"PTPI","cik":"0001815903","company_name":"Petros Pharmaceuticals, Inc.","filed_at":"2022-04-26T23:59:59+00:00","discovered_at":"2026-05-14T18:04:02.447472+00:00","generated_at":"2026-06-26T04:44:40.693852+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"medium","headline":"Petros Pharmaceuticals enters research agreement with Mass General for oxygenation sensor in erectile therapy","bullets":["Signed Sponsored Research Agreement and Option Agreement with Wellman Center of Massachusetts General Hospital.","Goal is to evaluate tissue-specific oxygenation sensor to monitor success of Erectile Device Therapy.","Option agreement allows Petros to negotiate an exclusive license of the sensor technology for specific human tissues.","Sensor intended to provide bio-sensor feedback for at-home penile therapy, enhancing existing erectile device therapy."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-050367","json":"https://secwatch.observer/filing/0001104659-22-050367.json","markdown":"https://secwatch.observer/filing/0001104659-22-050367.md","text":"https://secwatch.observer/filing/0001104659-22-050367.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1815903/000110465922050367/0001104659-22-050367-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1815903/000110465922050367/tm2213617d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T04:44:40.693852+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}